Login to Your Account

Washington Roundup

FDA Takes Steps to Alleviate Two Severe Drug Shortages

By Mari Serebrov
Washington Editor

Wednesday, February 22, 2012
WASHINGTON – Flexing its regulatory discretion, the FDA curbed two critical cancer drug shortages by speeding approval of a new source for preservative-free methotrexate and allowing the temporary importation of Lipodox as an alternative to Doxil.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription